142 related articles for article (PubMed ID: 6448581)
1. In vitro activity of cefoperazone against nonfermenters and Aeromonas hydrophila.
Fass RJ
Antimicrob Agents Chemother; 1980 Sep; 18(3):483-6. PubMed ID: 6448581
[TBL] [Abstract][Full Text] [Related]
2. Comparative activities of the oxa-beta-lactam LY127935, cefotaxime, cefoperazone, cefamandole, and ticarcillin against multiply resistant gram-negative bacilli.
Hall WH; Opfer BJ; Gerding DN
Antimicrob Agents Chemother; 1980 Feb; 17(2):273-9. PubMed ID: 6247970
[TBL] [Abstract][Full Text] [Related]
3. In vitro activity of new cephalosporins against multi-resistant gram-negative bacteria.
Fainstein V; Le Blanc B; Bodey GP
Infection; 1983; 11 Suppl 1():S20-2. PubMed ID: 6832840
[TBL] [Abstract][Full Text] [Related]
4. In vitro susceptibilities of Aeromonas hydrophila, Aeromonas sobria, and Aeromonas caviae to 22 antimicrobial agents.
Motyl MR; McKinley G; Janda JM
Antimicrob Agents Chemother; 1985 Jul; 28(1):151-3. PubMed ID: 4037775
[TBL] [Abstract][Full Text] [Related]
5. Comparative study of the biotype, hemolysin-producing capability and antibiogram of the aquatic and the clinical strains of Aeromonas hydrophila.
Tsai WC; Lee CH; Ju YC
Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1986 May; 19(2):124-36. PubMed ID: 3816361
[TBL] [Abstract][Full Text] [Related]
6. Comparative in vitro activity of cefpirome and cefepime, two new cephalosporins.
King A; Boothman C; Phillips I
Eur J Clin Microbiol Infect Dis; 1990 Sep; 9(9):677-85. PubMed ID: 2226498
[TBL] [Abstract][Full Text] [Related]
7. In vitro susceptibility of Aeromonas caviae, Aeromonas hydrophila and Aeromonas sobria to fifteen antibacterial agents.
Burgos A; Quindós G; Martínez R; Rojo P; Cisterna R
Eur J Clin Microbiol Infect Dis; 1990 Jun; 9(6):413-7. PubMed ID: 2387294
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the activity of cefoperazone, cefuroxime and cefoxitin against Gram-negative bacilli and synergy studies with cefoperazone and ticarcillin.
Miles HM; Carson M; Pavillard ER
Drugs; 1981; 22 Suppl 1():15-9. PubMed ID: 6456885
[TBL] [Abstract][Full Text] [Related]
9. In vitro susceptibilities of Aeromonas hydrophila to 32 antimicrobial agents.
Fass RJ; Barnishan J
Antimicrob Agents Chemother; 1981 Feb; 19(2):357-8. PubMed ID: 7347568
[TBL] [Abstract][Full Text] [Related]
10. In vitro activity of a new semisynthetic cephalosporin: cefoperazone.
Auckenthaler R; Waldvogel FA
Clin Ther; 1980; 3(Spec Issue):89-97. PubMed ID: 6446401
[TBL] [Abstract][Full Text] [Related]
11. In vitro susceptibilities of Aeromonas hydrophila against new antibiotics.
Fainstein V; Weaver S; Bodey GP
Antimicrob Agents Chemother; 1982 Sep; 22(3):513-4. PubMed ID: 7137987
[TBL] [Abstract][Full Text] [Related]
12. Antimicrobial activity and spectrum of cefoperazone against recent clinical isolates.
Jones RN; Fuchs PC; Barry AL; Gavan TL; Gerlach EH; Sommers HM
Clin Ther; 1980; 3(Spec Issue):14-23. PubMed ID: 6446389
[No Abstract] [Full Text] [Related]
13. Comparative activity of cefotaxime and selected beta-lactam antibiotics against Haemophilus influenzae and aerobic gram-negative bacilli.
Dabernat HJ; Delmas C
Rev Infect Dis; 1982; 4 Suppl():S401-5. PubMed ID: 6294790
[TBL] [Abstract][Full Text] [Related]
14. [Comparison of antimicrobial activity and stability to beta-lactamases of cefoperazone, cefotaxime, lamoxactam and ceftriaxon].
Baumgärtner M; Grehn M; Wundt W
Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1982 Jun; 252(2):208-21. PubMed ID: 6289564
[TBL] [Abstract][Full Text] [Related]
15. Susceptibilities of motile Aeromonas sp. to antimicrobial agents.
Kaznowski A; Włodarczak K
Zentralbl Bakteriol; 1991 Apr; 275(1):85-93. PubMed ID: 1930569
[TBL] [Abstract][Full Text] [Related]
16. Moxalactam (LY127935), a new semisynthetic 1-oxa-beta-lactam antibiotic with remarkable antimicrobial activity: in vitro comparison with cefamandole and tobramycin.
Jones RN; Fuchs PC; Sommers HM; Gavan TL; Barry AL; Gerlach EH
Antimicrob Agents Chemother; 1980 Apr; 17(4):750-6. PubMed ID: 6446880
[TBL] [Abstract][Full Text] [Related]
17. [Minimal inhibitory and bactericidal concentrations of cefoperazone, cefotaxime, cefuroxime and cefalotin against 90 bacterial strains].
Mascellino MT; Prignano G; Iegri F; Lorenzi A
Boll Ist Sieroter Milan; 1982; 61(4):309-19. PubMed ID: 6100234
[TBL] [Abstract][Full Text] [Related]
18. The comparative in vitro susceptibility of cefazolin-resistant organisms to six cephalosporins, four penicillins, and three aminoglycosides.
Chan EL; Birk RJ; Zabransky RJ
Diagn Microbiol Infect Dis; 1985 Nov; 3(6):525-33. PubMed ID: 3851708
[TBL] [Abstract][Full Text] [Related]
19. Cefoperazone (T-1551), a new semisynthetic cephalosporin: comparison with cephalothin and gentamicin.
Jones RN; Fuchs PC; Barry AL; Gavan TL; Sommers HM; Gerlach EH
Antimicrob Agents Chemother; 1980 Apr; 17(4):743-9. PubMed ID: 6446879
[TBL] [Abstract][Full Text] [Related]
20. Lomefloxacin (SC 47111 or NY-198), a new difluorinated quinolone: comparison of the in vitro activity with other broad spectrum antimicrobials against Enterobacteriaceae, Acinetobacter spp, Aeromonas spp, and Pseudomonas aeruginosa.
Aldridge KE; Henderberg A; Sanders CV
Diagn Microbiol Infect Dis; 1989; 12(3 Suppl):1S-6S. PubMed ID: 2507219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
